| Original language | English |
|---|---|
| Pages (from-to) | E29-E32 |
| Number of pages | 4 |
| Journal | American Journal of Hematology |
| Volume | 96 |
| Issue number | 1 |
| Early online date | 11 Nov 2020 |
| DOIs |
|
| Publication status | Published - Jan 2021 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: American Journal of Hematology, Vol. 96, No. 1, 01.2021, p. E29-E32.
Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review
TY - JOUR
T1 - Oxygen gradient ektacytometry-derived biomarkers are associated with vaso-occlusive crises and correlate with treatment response in sickle cell disease
AU - Rab, Minke A E
AU - Kanne, Celeste K
AU - Bos, Jennifer
AU - van Oirschot, Brigitte A
AU - Boisson, Camille
AU - Houwing, Maite E
AU - Gerritsma, Jorn
AU - Teske, Erik
AU - Renoux, Celine
AU - Riedl, Jurgen
AU - Schutgens, Roger E G
AU - Bartels, Marije
AU - Nur, Erfan
AU - Joly, Philippe
AU - Fort, Romain
AU - Cnossen, Marjon H
AU - van Wijk, Richard
AU - Connes, Philippe
AU - van Beers, Eduard J
AU - Sheehan, Vivien A
N1 - Funding Information: Both M.A.E.R., M.E.H., J.G., E.N., M.H.C., and E.J.v.B. are clinical researchers within the Sickle Cell Outcome Research (SCORE) consortium, a multicenter clinical research collaboration in the Netherlands, which gave input on the work described in this manuscript for which we value highly. This research has been funded in part by Eurostars grant estar18105 and by an unrestricted grant provided by RR Mechatronics. This work is also funded by K08 grant from the National Institute of Diabetes and Digestive and Kidney Diseases, and by support from the Department of Pediatrics, Baylor College of Medicine. Funding Information: M.A.E.R., J.B., and B.A.vO. received grant funding from RR Mechatronics. R.v.W. received grant funding from Agios Pharmaceuticals Inc and RR Mechatronics. E.J.v.B. received grant funding Agios Pharmaceuticals Inc, RR Mechatronics, Novartis and Pfizer for investigator initiated research projects. V.A.S. received grant funding from Global Blood Therapeutics, Emmaus, and Novartis for investigator initiated research projects. Funding Information: The authors would like to thank all patients that donated blood for this study. The authors also thank the technicians of the Central Diagnostic Laboratory, Specialized Hematology, University Medical Center Utrecht. As well as the clinical research coordinators of the department of pediatric hematology at the Erasmus Medical Center Rotterdam and the department of hematology at the Amsterdam University Medical Centers. Both M.A.E.R., M.E.H., J.G., E.N., M.H.C., and E.J.v.B. are clinical researchers within the Sickle Cell Outcome Research (SCORE) consortium, a multicenter clinical research collaboration in the Netherlands, which gave input on the work described in this manuscript for which we value highly. This research has been funded in part by Eurostars grant estar18105 and by an unrestricted grant provided by RR Mechatronics. This work is also funded by K08 grant from the National Institute of Diabetes and Digestive and Kidney Diseases, and by support from the Department of Pediatrics, Baylor College of Medicine.
PY - 2021/1
Y1 - 2021/1
UR - http://www.scopus.com/inward/record.url?scp=85096711024&partnerID=8YFLogxK
U2 - 10.1002/ajh.26031
DO - 10.1002/ajh.26031
M3 - Comment/Letter to the editor
C2 - 33095451
SN - 0361-8609
VL - 96
SP - E29-E32
JO - American Journal of Hematology
JF - American Journal of Hematology
IS - 1
ER -